Synopsis
The ability to exploit information through computational chemistry is vital for any modern drug hunter wishing to develop a therapeutic more efficiently and effectively. This meeting will focus on conceptual understanding of key topics, from basic theory to applied case studies. Topics range from cheminformatics and model building to computational-driven drug design and structural understanding.
Experienced speakers from academia and leading pharmaceutical companies will deliver informative lectures with emphasis on Q&A and other interactive elements to maximise learning opportunities.
Attendees
This event is intended for any drug hunters in academia or industry who would like to expand their understanding of computational techniques. It will also be of interest for those who would like to know more about how computational chemistry is applied in drug discovery.
Programme
Tuesday 14 October 2025
- 09.30
- Registration and refreshments
- 10.15
- Computational chemistry basics for medicinal chemists
Andreas Ritzén, Novo Nordisk
- 10.55
- The modern medicinal chemist
Lewis Vidler, Eli Lilly
- 11.35
- Artificial intelligence in drug discovery – aspects of data and impact on model performance and model applicability
Andreas Bender, Khalifa University
- 12.15
- Lunch and exhibition
- 13.15
- Cheminformatics and matched molecular pairs in medicinal chemistry
Jess Stacey, MedChemica
- 13.55
- Torsions and shapes in action: finding inspiration in the CCDC and the PDB
Gilles Ouvry, NRG
- 14.35
- Refreshment break
- 15.00
- Ligand based design in the alphafold age
David Clark, Charles River Laboratories
- 15.40
- Applying computational chemistry to antibody design
Mabel Wong, UCB
- 16.20
- Round table discussion with day one speakers
- 16.50
- Networking reception
Wednesday 15 October 2025
- 09.30
- Structure based design - It's more than just docking!
Louise Birch, Sygnature
- 10.10
- Free energy calculations in drug discovery
Stephan Ehrlich, UCB
- 10.50
- Refreshment break
- 11.15
- Title to be confirmed
Simon Richards, Isomorphic Labs
- 11.55
- Accelerating decision-making in drug design: Leveraging AI-driven strategies to reduce safety risks
Vigneshwari Subramanian, AstraZeneca
- 12.35
- Lunch and exhibition
- 13.35
- Applications of chemoinformatics and computational chemistry towards TPD design
Richard Sherhod, Amphista Therapeutics
- 14.15
- AI in drug discovery – Is this the real life? Is this just fantasy?
Pat Walters, Relay Therapeutics
- 14.55
- Refreshment break
- 15.20
- Crystallography: The good, the bad, and the ugly
Jason Cole, CCDC
- 16.00
- Round table discussion with day two speakers
- 16.30
- Close of event
SCI’s Young Chemists’ Panel are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with inclusivity of gender and ethnicity. Attendees from all backgrounds and ages are welcome.
Exhibition and sponsorship information
Please see the
sponsorship pack and email
conferences@soci.org to let us know which package you are interested in.
Accessibility Grants
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Venue and Contact
Fees
Early bird - ends Tuesday 9 September
SCI Member - £145
Non-member - £220
Student Member - £80 |
After early bird
SCI Member - £195
Non-member - £270
Student Member - £100 |
All registrations will automatically receive a confirmation within 24 hours of registering for the event. Should you not receive written confirmation of your booking, please email conferences@soci.org.
Become an SCI Member and save on this and future events
See Membership Options
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
Booking terms and conditions
CPD Info
All delegates attending this meeting are able to claim CPD points.

Organising committee
Sam Dalton, Isomorphic Labs
Lily Hunnisett, CCDC
Kevin Munro, Bioascent
Dominik Reich, Nxera
Adam Smalley, UCB